Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The exosomes derived from CAR-T cell efficiently target mesothelin and reduce triple-negative breast cancer growth
Pengxiang Yang, Xingjian Cao, Huilong Cai, et al.
Cellular Immunology (2020) Vol. 360, pp. 104262-104262
Closed Access | Times Cited: 121

Showing 1-25 of 121 citing articles:

Emerging role of exosomes in cancer progression and tumor microenvironment remodeling
Mahshid Deldar Abad Paskeh, Maliheh Entezari, Sepideh Mirzaei, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 364
Extracellular vesicles as tools and targets in therapy for diseases
Mudasir A. Kumar, Sadaf Khursheed Baba, Hana Q. Sadida, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 291
Natural and synthetic nanovectors for cancer therapy
Aziz Eftekhari, Carola Kryschi, David Pamies, et al.
Nanotheranostics (2023) Vol. 7, Iss. 3, pp. 236-257
Open Access | Times Cited: 112
Engineered extracellular vesicles and their mimetics for cancer immunotherapy
Chunping Liu, Yichao Wang, Longmei Li, et al.
Journal of Controlled Release (2022) Vol. 349, pp. 679-698
Closed Access | Times Cited: 105
New advances in exosome-based targeted drug delivery systems
Débora Ferreira, João Nuno Moreira, L. R. Rodrigues
Critical Reviews in Oncology/Hematology (2022) Vol. 172, pp. 103628-103628
Open Access | Times Cited: 98
Challenges and new technologies in adoptive cell therapy
Pengchao Zhang, Guizhong Zhang, Xiaochun Wan
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 82
Exosomes as smart drug delivery vehicles for cancer immunotherapy
Huan Zhang, Simiao Wang, Man Sun, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 55
Modification of immune cell-derived exosomes for enhanced cancer immunotherapy: current advances and therapeutic applications
Inseong Jung, Sanghee Shin, Moon‐Chang Baek, et al.
Experimental & Molecular Medicine (2024) Vol. 56, Iss. 1, pp. 19-31
Open Access | Times Cited: 46
Targeting Senescent Alveolar Epithelial Cells Using Engineered Mesenchymal Stem Cell-Derived Extracellular Vesicles To Treat Pulmonary Fibrosis
Yaoying Long, B. S. Yang, Qian Lei, et al.
ACS Nano (2024) Vol. 18, Iss. 9, pp. 7046-7063
Closed Access | Times Cited: 18
Exploring the dynamic interplay between exosomes and the immune tumor microenvironment: implications for breast cancer progression and therapeutic strategies
Sahar Safaei, Manouchehr Fadaee, Omid Rahbar Farzam, et al.
Breast Cancer Research (2024) Vol. 26, Iss. 1
Open Access | Times Cited: 16
Exosomes: Potential Disease Biomarkers and New Therapeutic Targets
María Isabel Mosquera Heredia, Luis Carlos Morales, Oscar M. Vidal, et al.
Biomedicines (2021) Vol. 9, Iss. 8, pp. 1061-1061
Open Access | Times Cited: 97
Immune Cell-Derived Extracellular Vesicles – New Strategies in Cancer Immunotherapy
Pengxiang Yang, Yong Peng, Feng Yuan, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 76
The Expanding Arsenal of Cytotoxic T Cells
Chiara Cassioli, Cosima T. Baldari
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 57
Extracellular vesicles: emerging anti-cancer drugs and advanced functionalization platforms for cancer therapy
Wu Manling, Min Wang, Haoyuan Jia, et al.
Drug Delivery (2022) Vol. 29, Iss. 1, pp. 2513-2538
Open Access | Times Cited: 51
Tumor buster - where will the CAR-T cell therapy ‘missile’ go?
Chunrun Qu, Hao Zhang, Hui Cao, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 45
The roles of small extracellular vesicles in cancer and immune regulation and translational potential in cancer therapy
Kewen Qian, Wenyan Fu, Tian Li, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 43
Engineered T cell extracellular vesicles displaying PD-1 boost anti-tumor immunity
Baoqi Li, Tianliang Fang, Yuan Li, et al.
Nano Today (2022) Vol. 46, pp. 101606-101606
Closed Access | Times Cited: 40
Extracellular vesicles as next generation immunotherapeutics
David W. Greening, Rong Xu, Anukreity Ale, et al.
Seminars in Cancer Biology (2023) Vol. 90, pp. 73-100
Closed Access | Times Cited: 40
Extracellular vesicles remodel tumor environment for cancer immunotherapy
Yue Ming, Shengyun Hu, Haifeng Sun, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 37
Harnessing Engineered Immune Cells and Bacteria as Drug Carriers for Cancer Immunotherapy
Jingwen Jiang, Yanjuan Huang, Zishan Zeng, et al.
ACS Nano (2023) Vol. 17, Iss. 2, pp. 843-884
Closed Access | Times Cited: 28
T cell-derived exosomes in tumor immune modulation and immunotherapy
Qiujun Zhou, Shenyu Wei, Hui Wang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 25
The role of MSCs and CAR-MSCs in cellular immunotherapy
Lun Yan, Jing Li, Cheng Zhang
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 23
Engineering exosomes to reshape the immune microenvironment in breast cancer: Molecular insights and therapeutic opportunities
Jilong Cao, Gang Lv, Wei Fang
Clinical and Translational Medicine (2024) Vol. 14, Iss. 4
Open Access | Times Cited: 15
Fusion of Exosomes and Nanotechnology: Cutting-Edge Cancer Theranostics
R. Agnihotram, Rajib Dhar, Debolina Dhar, et al.
ACS Applied Nano Materials (2024) Vol. 7, Iss. 8, pp. 8489-8506
Closed Access | Times Cited: 14
CAR-based immunotherapy for breast cancer: peculiarities, ongoing investigations, and future strategies
Zhipu Niu, Jingyuan Wu, Qiancheng Zhao, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top